Cargando…

Back to BAC: The Use of Infectious Clone Technologies for Viral Mutagenesis

Bacterial artificial chromosome (BAC) vectors were first developed to facilitate the propagation and manipulation of large DNA fragments in molecular biology studies for uses such as genome sequencing projects and genetic disease models. To facilitate these studies, methodologies have been developed...

Descripción completa

Detalles Bibliográficos
Autores principales: Hall, Robyn N., Meers, Joanne, Fowler, Elizabeth, Mahony, Timothy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315213/
https://www.ncbi.nlm.nih.gov/pubmed/22470833
http://dx.doi.org/10.3390/v4020211
_version_ 1782228200556855296
author Hall, Robyn N.
Meers, Joanne
Fowler, Elizabeth
Mahony, Timothy
author_facet Hall, Robyn N.
Meers, Joanne
Fowler, Elizabeth
Mahony, Timothy
author_sort Hall, Robyn N.
collection PubMed
description Bacterial artificial chromosome (BAC) vectors were first developed to facilitate the propagation and manipulation of large DNA fragments in molecular biology studies for uses such as genome sequencing projects and genetic disease models. To facilitate these studies, methodologies have been developed to introduce specific mutations that can be directly applied to the mutagenesis of infectious clones (icBAC) using BAC technologies. This has resulted in rapid identification of gene function and expression at unprecedented rates. Here we review the major developments in BAC mutagenesis in vitro. This review summarises the technologies used to construct and introduce mutations into herpesvirus icBAC. It also explores developing technologies likely to provide the next leap in understanding these important viruses.
format Online
Article
Text
id pubmed-3315213
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-33152132012-04-02 Back to BAC: The Use of Infectious Clone Technologies for Viral Mutagenesis Hall, Robyn N. Meers, Joanne Fowler, Elizabeth Mahony, Timothy Viruses Review Bacterial artificial chromosome (BAC) vectors were first developed to facilitate the propagation and manipulation of large DNA fragments in molecular biology studies for uses such as genome sequencing projects and genetic disease models. To facilitate these studies, methodologies have been developed to introduce specific mutations that can be directly applied to the mutagenesis of infectious clones (icBAC) using BAC technologies. This has resulted in rapid identification of gene function and expression at unprecedented rates. Here we review the major developments in BAC mutagenesis in vitro. This review summarises the technologies used to construct and introduce mutations into herpesvirus icBAC. It also explores developing technologies likely to provide the next leap in understanding these important viruses. MDPI 2012-02-03 /pmc/articles/PMC3315213/ /pubmed/22470833 http://dx.doi.org/10.3390/v4020211 Text en © 2012 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Hall, Robyn N.
Meers, Joanne
Fowler, Elizabeth
Mahony, Timothy
Back to BAC: The Use of Infectious Clone Technologies for Viral Mutagenesis
title Back to BAC: The Use of Infectious Clone Technologies for Viral Mutagenesis
title_full Back to BAC: The Use of Infectious Clone Technologies for Viral Mutagenesis
title_fullStr Back to BAC: The Use of Infectious Clone Technologies for Viral Mutagenesis
title_full_unstemmed Back to BAC: The Use of Infectious Clone Technologies for Viral Mutagenesis
title_short Back to BAC: The Use of Infectious Clone Technologies for Viral Mutagenesis
title_sort back to bac: the use of infectious clone technologies for viral mutagenesis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315213/
https://www.ncbi.nlm.nih.gov/pubmed/22470833
http://dx.doi.org/10.3390/v4020211
work_keys_str_mv AT hallrobynn backtobactheuseofinfectiousclonetechnologiesforviralmutagenesis
AT meersjoanne backtobactheuseofinfectiousclonetechnologiesforviralmutagenesis
AT fowlerelizabeth backtobactheuseofinfectiousclonetechnologiesforviralmutagenesis
AT mahonytimothy backtobactheuseofinfectiousclonetechnologiesforviralmutagenesis